Twist Bioscience Corp at UBS Global Healthcare Conference (Virtual) Transcript
Hey, good morning. Thank you, everyone, for attending the UBS Virtual Health Care Conference. This is Gregg Genova from the UBS equity sales team. The session is a fireside chat with Twist Biosciences. Happy to have here with me, Emily Leproust, Founder and CEO; and Jim Thorburn, CFO. So I have plenty of questions prepared. If you'd like to ask a question, please use the UBS conference website to input a question, and I'll be happy to ask Emily and Jim.
Questions & Answers
So with that, why don't I jump right in? So of course, front and center right now is COVID-19. I know you guys had some puts and takes. So let's first cover the positives. You had nearly, I think, $500,000 in revenue on the positive side from 3 main areas: the reference sequences, the enrichment panel, and of course, the custom
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |